Chargement en cours...
Can biosimilars help achieve the goals of US health care reform?
The US Patient Protection and Affordable Care Act (ACA) aims to expand health care coverage, contain costs, and improve health care quality. Accessibility and affordability of innovative biopharmaceuticals are important to the success of the ACA. As it is substantially more difficult to manufacture...
Enregistré dans:
| Publié dans: | Cancer Manag Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459961/ https://ncbi.nlm.nih.gov/pubmed/28615973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S133442 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|